Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
Glycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/01998 |
_version_ | 1811200302168145920 |
---|---|
author | Jennifer L Stamos Matthew Ling-Hon Chu Michael D Enos Niket Shah William I Weis |
author_facet | Jennifer L Stamos Matthew Ling-Hon Chu Michael D Enos Niket Shah William I Weis |
author_sort | Jennifer L Stamos |
collection | DOAJ |
description | Glycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near the amino terminus of GSK-3 generates an auto-inhibitory peptide. In contrast, Wnt/β-catenin signal transduction requires phosphorylation of Ser/Pro rich sequences present in the Wnt co-receptors LRP5/6, and these motifs inhibit GSK-3 activity. We present crystal structures of GSK-3 bound to its phosphorylated N-terminus and to two of the phosphorylated LRP6 motifs. A conserved loop unique to GSK-3 undergoes a dramatic conformational change that clamps the bound pseudo-substrate peptides, and reveals the mechanism of primed substrate recognition. The structures rationalize target sequence preferences and suggest avenues for the design of inhibitors selective for a subset of pathways regulated by GSK-3. |
first_indexed | 2024-04-12T02:02:29Z |
format | Article |
id | doaj.art-7c15a261e8bd48adb929dd7023bf8741 |
institution | Directory Open Access Journal |
issn | 2050-084X |
language | English |
last_indexed | 2024-04-12T02:02:29Z |
publishDate | 2014-03-01 |
publisher | eLife Sciences Publications Ltd |
record_format | Article |
series | eLife |
spelling | doaj.art-7c15a261e8bd48adb929dd7023bf87412022-12-22T03:52:38ZengeLife Sciences Publications LtdeLife2050-084X2014-03-01310.7554/eLife.01998Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6Jennifer L Stamos0Matthew Ling-Hon Chu1Michael D Enos2Niket Shah3William I Weis4Department of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesGlycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near the amino terminus of GSK-3 generates an auto-inhibitory peptide. In contrast, Wnt/β-catenin signal transduction requires phosphorylation of Ser/Pro rich sequences present in the Wnt co-receptors LRP5/6, and these motifs inhibit GSK-3 activity. We present crystal structures of GSK-3 bound to its phosphorylated N-terminus and to two of the phosphorylated LRP6 motifs. A conserved loop unique to GSK-3 undergoes a dramatic conformational change that clamps the bound pseudo-substrate peptides, and reveals the mechanism of primed substrate recognition. The structures rationalize target sequence preferences and suggest avenues for the design of inhibitors selective for a subset of pathways regulated by GSK-3.https://elifesciences.org/articles/01998GSK-3Wnt signalingprotein kinaseLRP6 |
spellingShingle | Jennifer L Stamos Matthew Ling-Hon Chu Michael D Enos Niket Shah William I Weis Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 eLife GSK-3 Wnt signaling protein kinase LRP6 |
title | Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 |
title_full | Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 |
title_fullStr | Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 |
title_full_unstemmed | Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 |
title_short | Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 |
title_sort | structural basis of gsk 3 inhibition by n terminal phosphorylation and by the wnt receptor lrp6 |
topic | GSK-3 Wnt signaling protein kinase LRP6 |
url | https://elifesciences.org/articles/01998 |
work_keys_str_mv | AT jenniferlstamos structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6 AT matthewlinghonchu structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6 AT michaeldenos structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6 AT niketshah structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6 AT williamiweis structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6 |